Literature DB >> 7523369

Misincorporation and mispaired primer extension by human immunodeficiency virus reverse transcriptase.

S Zinnen1, J C Hsieh, P Modrich.   

Abstract

Pre-steady-state methods were used to study the fidelity of human immunodeficiency virus reverse transcriptase. Fidelity of DNA-directed DNA synthesis can be attributed to a 1-2 order of magnitude reduction in affinity for noncomplementary dNTPs, and a 1-4 order of magnitude reduction in the rate of the conformational change that limits the rate of nucleotide addition. Affinities of reverse transcriptase for paired or mispaired primer termini are similar. Discrimination against a mispaired primer is due to reduction in affinity for the next dNTP and reduction in rate of extension. Extension of mispaired termini proceeds 20-700-fold faster than the rate of dissociation of reverse transcriptase from the primer-template and is 2-3 orders of magnitude more frequent than nucleotide misincorporation. The rate-limiting step for extension of a mispaired terminus occurs at the conformational change or chemical step, depending on the nature of the mispair. Presence of a mismatch at the 3' penultimate position reduces pyrophosphorolysis of the primer by a factor of 10(3), indicating that mispairs 5' to the site of chemistry can also affect catalysis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523369

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  K65R and K65A substitutions in HIV-1 reverse transcriptase enhance polymerase fidelity by decreasing both dNTP misinsertion and mispaired primer extension efficiencies.

Authors:  Scott J Garforth; Robert A Domaoal; Chisanga Lwatula; Mark J Landau; Amanda J Meyer; Karen S Anderson; Vinayaka R Prasad
Journal:  J Mol Biol       Date:  2010-06-09       Impact factor: 5.469

2.  Stereo-selectivity of HIV-1 reverse transcriptase toward isomers of thymidine-5'-O-1-thiotriphosphate.

Authors:  Jessica Radzio; Nicolas Sluis-Cremer
Journal:  Protein Sci       Date:  2005-06-03       Impact factor: 6.725

3.  Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses.

Authors:  Qing Xia; Jessica Radzio; Karen S Anderson; Nicolas Sluis-Cremer
Journal:  Protein Sci       Date:  2007-08       Impact factor: 6.725

4.  The effect of primer-template mismatches on the detection and quantification of nucleic acids using the 5' nuclease assay.

Authors:  Ralph Stadhouders; Suzan D Pas; Jeer Anber; Jolanda Voermans; Ted H M Mes; Martin Schutten
Journal:  J Mol Diagn       Date:  2009-11-30       Impact factor: 5.568

Review 5.  Error-prone retrotransposition: rime of the ancient mutators.

Authors:  B D Preston
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

6.  Replication infidelity during a single cycle of Ty1 retrotransposition.

Authors:  A Gabriel; M Willems; E H Mules; J D Boeke
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

7.  Replication errors during in vivo Ty1 transposition are linked to heterogeneous RNase H cleavage sites.

Authors:  E H Mules; O Uzun; A Gabriel
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

8.  Determination of the site of first strand transfer during Moloney murine leukemia virus reverse transcription and identification of strand transfer-associated reverse transcriptase errors.

Authors:  D Kulpa; R Topping; A Telesnitsky
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

9.  The mechano-chemistry of a monomeric reverse transcriptase.

Authors:  Omri Malik; Hadeel Khamis; Sergei Rudnizky; Ariel Kaplan
Journal:  Nucleic Acids Res       Date:  2017-12-15       Impact factor: 16.971

10.  Activity and fidelity of human DNA polymerase α depend on primer structure.

Authors:  Andrey G Baranovskiy; Vincent N Duong; Nigar D Babayeva; Yinbo Zhang; Youri I Pavlov; Karen S Anderson; Tahir H Tahirov
Journal:  J Biol Chem       Date:  2018-03-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.